ALZAMEND NEURO INC. -

0,7600

15-апреля-25 16:45:00

15 мин. задержка

Акции

-0,0290

-3,68%

Сегодняшний диапазон

0,7592 - 0,8220

ISIN

N/A

Источник

NASDAQ

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

25 мар 2025 08:00:01 Источник Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

18 мар 2025 08:00:00 Источник Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

11 мар 2025 08:00:00 Источник Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

04 мар 2025 08:10:00 Источник Nasdaq GlobeNewswire
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

25 фев 2025 08:00:59 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.